BEC Partners with Supernus Pharmaceuticals

10 Jan, 2023

At BEC, we’re proud to measure our most successful partnerships not in months or even years, but in decades. This December, we’re excited to begin a sales organization expansion with our longtime partner, Supernus Pharmaceuticals, Inc..
Supernus is a biopharmaceutical company that develops products to treat the central nervous system, and their newest treatment, Qelbree® has recently been approved by the FDA. As the first non-stimulant ADHD treatment option approved for adults in over 20 years, Qelbree is expected to have a major impact on the market.
This December, we’ve set our sights on helping Supernus develop the sales organization that will ensure Qelbree receives the attention it deserves. Thanks to our Direct Recruiting Outsourcing (DRO) advantage, we’re confident that Supernus’ newest team will be stacked with top performers ready to get the job done.
We’re incredibly grateful for our partnership with Supernus and look forward to our future projects together. Follow us on LinkedIn!